MARKET

GSK

GSK

GSK PLC
NYSE
50.45
+0.26
+0.52%
After Hours: 50.45 0 0.00% 19:30 11/13 EST
OPEN
50.25
PREV CLOSE
50.19
HIGH
50.80
LOW
50.13
VOLUME
2.78M
TURNOVER
--
52 WEEK HIGH
59.59
52 WEEK LOW
44.24
MARKET CAP
102.05B
P/E (TTM)
17.80
1D
5D
1M
3M
1Y
5Y
1D
Cigarette Sales Keep Falling. These 2 Tobacco Stocks Still Pay 5.5% Dividends
24/7 Wall St. · 5h ago
Measles cases rise to over 5,400 across US
Seeking Alpha · 1d ago
GSK Reports Positive CHMP Opinion for One-Dose Bexsero Booster
TipRanks · 1d ago
GSK price target lowered to 2,050 GBp from 2,100 GBp at Citi
TipRanks · 2d ago
GSK Updates NASH Drug Study as Investors Await Results
TipRanks · 2d ago
GSK Reports Five PDMRs’ Share Reward Plan Acquisitions
TipRanks · 2d ago
GSK price target lowered to 2,050 GBp from 2,100 GBp at Citi
TipRanks · 3d ago
U.S. measles elimination status is at risk as regional WHO body holds annual meeting
Seeking Alpha · 3d ago
More
About GSK
GSK plc is a United Kingdom-based biopharma company. The Company is focused on the science of the immune system and advanced technologies, investing in four core therapeutic areas-respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its segments include Commercial Operations and Research and Development. Its specialty medicines prevent and treat diseases, from asthma, cancer and HIV to autoimmune diseases like lupus. General medicines include inhalers for asthma and chronic obstructive pulmonary disease (COPD) to antibiotics. It also owns ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody and HS235, a potential molecule for the treatment of pulmonary hypertension (PH). Its oncology portfolio also includes Zidesamtinib (NVL-520), neladalkib (NVL-655), and NVL-330. Its products include Anoro Ellipta, Apretude, Arexvy, Bexsero, Blenrep, Blujepa, Boostrix, Cervarix, Dovato, Efimosfermin, among others.

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.